NO20043489L - Sammensetning for inhalering - Google Patents

Sammensetning for inhalering

Info

Publication number
NO20043489L
NO20043489L NO20043489A NO20043489A NO20043489L NO 20043489 L NO20043489 L NO 20043489L NO 20043489 A NO20043489 A NO 20043489A NO 20043489 A NO20043489 A NO 20043489A NO 20043489 L NO20043489 L NO 20043489L
Authority
NO
Norway
Prior art keywords
inhalation
composition
Prior art date
Application number
NO20043489A
Other languages
English (en)
Inventor
Steve Burns
Philip Wikeley
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0200412A external-priority patent/SE0200412D0/xx
Priority claimed from SE0202138A external-priority patent/SE0202138D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20043489L publication Critical patent/NO20043489L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20043489A 2002-02-01 2004-08-20 Sammensetning for inhalering NO20043489L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0200412A SE0200412D0 (sv) 2002-02-01 2002-02-01 Novel composition
SE0202138A SE0202138D0 (sv) 2002-07-05 2002-07-05 Novel Composition
PCT/SE2003/000157 WO2003063843A1 (en) 2002-02-01 2003-01-29 Composition for inhalation

Publications (1)

Publication Number Publication Date
NO20043489L true NO20043489L (no) 2004-08-20

Family

ID=27667648

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043489A NO20043489L (no) 2002-02-01 2004-08-20 Sammensetning for inhalering

Country Status (10)

Country Link
US (1) US20050118107A1 (no)
EP (1) EP1474118A1 (no)
JP (1) JP2005530686A (no)
KR (1) KR20040081753A (no)
CN (1) CN1622802A (no)
BR (1) BR0307235A (no)
CA (1) CA2474690A1 (no)
MX (1) MXPA04007294A (no)
NO (1) NO20043489L (no)
WO (1) WO2003063843A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1809243T5 (pl) * 2004-07-02 2022-12-27 Boehringer Ingelheim International Gmbh Preparaty aerozolowe w postaci zawiesin z tg 227 ea jako propelent aerozolowy
DE102006017320A1 (de) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
WO2008152398A2 (en) * 2007-06-14 2008-12-18 Cipla Limited Formulations for inhalation
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
US20160310410A1 (en) 2015-04-24 2016-10-27 Glenmark Specialty S.A. Pharmaceutical compositions comprising arformoterol and glycopyrronium
CN106581010B (zh) * 2016-12-28 2019-03-05 四川普锐特医药科技有限责任公司 一种气溶胶制剂及定量吸入气雾剂
CN109464429B (zh) * 2018-12-13 2021-04-27 上海方予健康医药科技有限公司 一种吸入压力定量气雾剂药物组合物及其制备方法
CN110840864B (zh) * 2019-12-20 2022-02-22 广州健康元呼吸药物工程技术有限公司 一种β2受体激动剂吸入气雾剂及包含该吸入气雾剂的产品

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6123924A (en) * 1991-09-25 2000-09-26 Fisons Plc Pressurized aerosol inhalation compositions
WO1998021175A1 (en) * 1996-11-11 1998-05-22 Sepracor, Inc. Process for the preparation of optically pure isomers of formoterol
SE9704644D0 (sv) * 1997-12-12 1997-12-12 Astra Ab New use
GB0016876D0 (en) * 2000-07-11 2000-08-30 Astrazeneca Ab Novel formulation

Also Published As

Publication number Publication date
MXPA04007294A (es) 2004-10-29
CA2474690A1 (en) 2003-08-07
CN1622802A (zh) 2005-06-01
BR0307235A (pt) 2004-12-07
KR20040081753A (ko) 2004-09-22
WO2003063843A1 (en) 2003-08-07
US20050118107A1 (en) 2005-06-02
EP1474118A1 (en) 2004-11-10
JP2005530686A (ja) 2005-10-13

Similar Documents

Publication Publication Date Title
IS7471A (is) Ný efnasambönd
IS7879A (is) Ný efnasambönd
DE10393374D2 (de) Zusammensetzung
FR2862654B1 (fr) Composition amylacee filmogene
NO20050132D0 (no) Vaksinesammensetning
ATE368042T1 (de) Cephemverbindungen
SE0500163L (sv) Sammansättning
IS7827A (is) Ný efnasambönd
IS7381A (is) Efnasambönd
IS7414A (is) Oxó-azabísýklísk efnasambönd
DK3006462T3 (da) Alfa-1-antitrypsin-sammensætning
DE60310914D1 (de) Pulverzusammensetzung
DK1561472T3 (da) Faststofsammensætning
DE60320902D1 (de) Zusammensetzungen mit ausgelöster Freisetzung
NO20045659L (no) Forbindelser
DK1492934T3 (da) Dørenhed
NO20043489L (no) Sammensetning for inhalering
ITMI20020198A0 (it) (per)aloeteri
NO20044140D0 (no) New Composition
FI20031158A (fi) Inhalaattori
SE0201759D0 (sv) New Composition
SE0201667D0 (sv) New composition
SE0203348D0 (sv) Novel compounds
SE0200412D0 (sv) Novel composition
SE0202138D0 (sv) Novel Composition

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application